JP2007531736A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007531736A5 JP2007531736A5 JP2007506347A JP2007506347A JP2007531736A5 JP 2007531736 A5 JP2007531736 A5 JP 2007531736A5 JP 2007506347 A JP2007506347 A JP 2007506347A JP 2007506347 A JP2007506347 A JP 2007506347A JP 2007531736 A5 JP2007531736 A5 JP 2007531736A5
- Authority
- JP
- Japan
- Prior art keywords
- tumors
- compound
- tumor
- composition
- formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 0 *CC([C@]([C@@](C1*(C=C(*)C(*)=*2)C2=O)I)*#C)=C1I Chemical compound *CC([C@]([C@@](C1*(C=C(*)C(*)=*2)C2=O)I)*#C)=C1I 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US55814104P | 2004-04-01 | 2004-04-01 | |
| US60/558,141 | 2004-04-01 | ||
| PCT/US2005/011313 WO2005097757A2 (en) | 2004-04-01 | 2005-04-01 | Nucleoside derivatives and therapeutic use thereof |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012054597A Division JP2012107072A (ja) | 2004-04-01 | 2012-03-12 | ヌクレオシド誘導体およびそれらの治療用途 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2007531736A JP2007531736A (ja) | 2007-11-08 |
| JP2007531736A5 true JP2007531736A5 (enExample) | 2008-05-08 |
| JP5001832B2 JP5001832B2 (ja) | 2012-08-15 |
Family
ID=34979006
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007506347A Expired - Lifetime JP5001832B2 (ja) | 2004-04-01 | 2005-04-01 | ヌクレオシド誘導体およびそれらの治療用途 |
| JP2012054597A Withdrawn JP2012107072A (ja) | 2004-04-01 | 2012-03-12 | ヌクレオシド誘導体およびそれらの治療用途 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012054597A Withdrawn JP2012107072A (ja) | 2004-04-01 | 2012-03-12 | ヌクレオシド誘導体およびそれらの治療用途 |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US7405214B2 (enExample) |
| EP (1) | EP1732902B1 (enExample) |
| JP (2) | JP5001832B2 (enExample) |
| KR (1) | KR100926596B1 (enExample) |
| CN (2) | CN102091072A (enExample) |
| AT (1) | ATE453628T1 (enExample) |
| AU (1) | AU2005230676B2 (enExample) |
| BR (1) | BRPI0509553B8 (enExample) |
| CA (1) | CA2562965C (enExample) |
| DE (1) | DE602005018620D1 (enExample) |
| ES (1) | ES2334803T3 (enExample) |
| IN (1) | IN2014DN04587A (enExample) |
| MX (1) | MXPA06011141A (enExample) |
| PL (1) | PL1732902T3 (enExample) |
| WO (1) | WO2005097757A2 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9315534B2 (en) * | 2007-08-10 | 2016-04-19 | Board Of Regents Of The University Of Nebraska | Radiologic agents for monitoring alzheimer's disease progression and Evaluating a Response to Therapy and processes for the preparation of such agents |
| US20120269725A1 (en) * | 2009-12-23 | 2012-10-25 | Janine Baranowska-Kortylewicz | Targeted radiolabeled compounds and their use for the treatment and diagnosis of cancer |
| US9150520B2 (en) | 2013-03-15 | 2015-10-06 | Rexahn Pharmaceuticals, Inc. | Process for the preparation of 4-amino-1-((1S,4R,5S)-2-fluoro-4,5-dihydroxy-3-hydroxymethyl-cyclopent-2-enyl)-1H-pyrimidin-2-one |
| BR112017025742A2 (pt) * | 2015-06-09 | 2018-08-07 | Rexahn Pharmaceuticals, Inc. | métodos de uso de fluorciclopentanilcitosina |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6187674A (ja) * | 1984-10-06 | 1986-05-06 | Yoshitomi Pharmaceut Ind Ltd | シクロペンテン環を有する新規ヌクレオシド |
| US4975434A (en) * | 1986-05-27 | 1990-12-04 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Antiviral and anticancer cyclopentenyl cytosine |
| CA2426187C (en) * | 2000-10-18 | 2011-08-16 | Pharmasset Limited | Modified nucleosides for the treatment of viral infections and abnormal cellular proliferation |
| TWI299664B (en) * | 2003-01-06 | 2008-08-11 | Osi Pharm Inc | (2-carboxamido)(3-amino)thiophene compounds |
-
2005
- 2005-04-01 JP JP2007506347A patent/JP5001832B2/ja not_active Expired - Lifetime
- 2005-04-01 BR BRPI0509553A patent/BRPI0509553B8/pt active IP Right Grant
- 2005-04-01 ES ES05733004T patent/ES2334803T3/es not_active Expired - Lifetime
- 2005-04-01 WO PCT/US2005/011313 patent/WO2005097757A2/en not_active Ceased
- 2005-04-01 CN CN2010105546004A patent/CN102091072A/zh active Pending
- 2005-04-01 EP EP05733004A patent/EP1732902B1/en not_active Expired - Lifetime
- 2005-04-01 CN CN2005800178253A patent/CN1980898B/zh not_active Expired - Fee Related
- 2005-04-01 US US11/095,686 patent/US7405214B2/en not_active Expired - Lifetime
- 2005-04-01 DE DE602005018620T patent/DE602005018620D1/de not_active Expired - Lifetime
- 2005-04-01 AU AU2005230676A patent/AU2005230676B2/en not_active Expired
- 2005-04-01 AT AT05733004T patent/ATE453628T1/de not_active IP Right Cessation
- 2005-04-01 CA CA2562965A patent/CA2562965C/en not_active Expired - Lifetime
- 2005-04-01 KR KR1020067022856A patent/KR100926596B1/ko not_active Expired - Lifetime
- 2005-04-01 IN IN4587DEN2014 patent/IN2014DN04587A/en unknown
- 2005-04-01 MX MXPA06011141A patent/MXPA06011141A/es active IP Right Grant
- 2005-04-01 PL PL05733004T patent/PL1732902T3/pl unknown
-
2012
- 2012-03-12 JP JP2012054597A patent/JP2012107072A/ja not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2012153722A5 (enExample) | ||
| JP2022017295A5 (enExample) | ||
| JP2012509279A5 (enExample) | ||
| JP2019502675A5 (enExample) | ||
| JP2010528026A5 (enExample) | ||
| JP2017538677A5 (enExample) | ||
| JP2016006096A5 (enExample) | ||
| JP2006515859A5 (enExample) | ||
| JP2013545812A5 (enExample) | ||
| JP2014193925A5 (enExample) | ||
| JP2010518110A5 (enExample) | ||
| JP2007523177A5 (enExample) | ||
| JP2008528671A5 (enExample) | ||
| JP2007511504A5 (enExample) | ||
| CA2606719A1 (en) | Amorphous salt of 4-(3-chloro-4-(cyclopropylaminocarbonyl)aminophenoxy)-7-methoxy-6-quinolinecarboxamide and process for producing the same | |
| JP2012505916A5 (enExample) | ||
| JP2010502767A5 (enExample) | ||
| JP2017526662A5 (enExample) | ||
| JP2015512398A5 (enExample) | ||
| JP2017530171A5 (enExample) | ||
| JP2015509540A5 (enExample) | ||
| JP2018538292A5 (enExample) | ||
| JP2011516426A5 (enExample) | ||
| JP2008536853A5 (enExample) | ||
| JP2007531736A5 (enExample) |